Angelica Varesi: New Insights into Hematopoietic Stem Cell Biology
Angelica Varesi, PhD Student at the University of Toronto and Princess Margaret Cancer Centre, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in bioRxiv, adding:
”Excited to share our latest preprint is out!
Huge collaborative effort merging University Health Network University of Toronto and San Raffaele Telethon Institute for Gene Therapy (SR-Tiget)driven by our curiosity to go beyond gene-centric approaches to study hematopoietic stem cell biology using VEXAS syndrome as a model of clonal dominance and myeloid bias.
Many thanks to my PhD supervisor John Dick without whom this work would have never been possible, to my former advisor and still estimated mentor Samuele Ferrari who made a simple curiosity becoming a real biology discover, to Bowen Li and Songtao Dong who made two-hit genetic engineering feasible, and to all the team members, whose contribution was essential for this work.
Interested to understand how transposable elements play a role in hematopoiesis and disease?”
Title: Locus-specific transposable element expression drives human hematopoietic stem cell disease pathophysiology
Authors: Angelica Varesi, Sontago Dong, Chiara Gaddoni, Kerstin B. Kaufmann, Tevis Wong, Ivan Merelli, Andy G.X. Zeng, Jessica McLeod, Liqing Jin, Isabella di Biasio, Igor Novitzky-Basso, Jonas Mattson, Stephanie Z. Xie, Bowen Li, Samuele Ferrari, John E. Dick
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 04:27Ruth Fein: The Patient Impact of Transfusion Dependence in Myelofibrosis
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO